Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YY1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | KIF2A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | PALM | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | ZNF66 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | KIF19 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | CYP4F22 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | HOXA9 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | DAZAP1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
mRNA | TTC39B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | INTS6L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |